Loading data
QCLSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 3.47 m USD | 3.44 m USD | 7.87 m USD | 9.07 m USD | 6.75 m USD |
| Operating profit | -9.85 m USD | -10.17 m USD | -17.12 m USD | -15.28 m USD | -28.81 m USD |
| Profit before tax | -11.63 m USD | -23.36 m USD | -4 m USD | -15.2 m USD | -29.89 m USD |
| Net income (reported basis) | -11.63 m USD | -23.36 m USD | -8.22 m USD | -15.2 m USD | -29.89 m USD |
| Net income attributable to common shareholders | -14.98 m USD | -27.16 m USD | -8.22 m USD | -15.2 m USD | — |
| Basic earnings per share | -8.66 USD/share | -1,080.87 USD/share | -5.33 USD/share | -11.74 USD/share | -0.85 USD/share |
| Diluted earnings per share | -8.66 USD/share | -1,080.87 USD/share | -5.33 USD/share | -11.74 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.